Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trialMing-Ming He, Hui Luo, Teng Mao et al.|Med|2024Cited by 32
Differential efficacy of gefitinib across age groups in treatment of advanced lung adenocarcinomaHuijuan Wang, Zhiyong Ma, Guowei Zhang et al.|Die Pharmazie|2012Cited by 0